Written Resolutions of the Directors of Premium Selection UCITS ICAV – JP Morgan Emerging Opportunities
We, the undersigned, being all of the Directors of the ICAV for the time being entitled to attend and vote at Board meetings of the ICAV (each a “Director”, together the “Directors” or the “Board”) hereby resolve, pursuant to Clause 22.12 of the Instrument of Incorporation of the ICAV, and Section 91A of the Irish Collective Asset- Management Vehicles Act 2015, to approve the following resolutions:
1.1 IT IS NOTED that it is proposed to update the supplement in respect of JP Morgan Emerging Opportunities (the “Sub-Fund”) to reflect the change of investment manager which will be effective on or around 21 November 2025.
1.2 Following consideration, IT IS RESOLVED THAT having regard to the operational considerations related to the change of investment manager, the Directors shall exercise their discretion to specify that 20 November 2025 shall not be a ‘Business Day’ as defined in the supplement for the Sub-Fund (the “Supplement”).
1.3 It is further NOTED THAT where 20 November 2025 has been specified as not being a ‘Business Day’ as defined in the Supplement, it shall therefore also not be a ‘Dealing Day’ as defined in the Supplement and it was NOTED THAT shareholders will be provided with reasonable notification of this change.
These written resolutions may be executed in any number of counterparts each of which when executed and delivered by one or more of the Directors is an original, but all the counterparts together constitute the same document provided that these written resolutions shall not be effective until each Director has executed and delivered at least one counterpart.
Dated 22 October 2025